IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 203 filers reported holding IMMUNOMEDICS INC in Q2 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $3,732,000 | +27.4% | 105,318 | -51.5% | 0.06% | -20.0% |
Q1 2020 | $2,929,000 | +260.7% | 217,303 | +254.7% | 0.08% | +971.4% |
Q3 2019 | $812,000 | -67.7% | 61,264 | -53.2% | 0.01% | -74.1% |
Q1 2019 | $2,513,000 | +217.7% | 130,813 | +136.0% | 0.03% | +200.0% |
Q4 2018 | $791,000 | -47.5% | 55,430 | -23.4% | 0.01% | -50.0% |
Q3 2018 | $1,508,000 | -3.5% | 72,400 | +9.6% | 0.02% | -14.3% |
Q2 2018 | $1,563,000 | +177.1% | 66,050 | +71.0% | 0.02% | +133.3% |
Q1 2018 | $564,000 | -6.5% | 38,625 | +3.5% | 0.01% | -18.2% |
Q4 2017 | $603,000 | +64.8% | 37,304 | +42.5% | 0.01% | +57.1% |
Q3 2017 | $366,000 | +171.1% | 26,180 | +71.3% | 0.01% | +133.3% |
Q2 2017 | $135,000 | +3.8% | 15,280 | -56.9% | 0.00% | -40.0% |
Q4 2016 | $130,000 | +209.5% | 35,471 | +176.6% | 0.01% | +66.7% |
Q3 2016 | $42,000 | – | 12,825 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |